Cover Image

CXCR4/CXCL12 axis: “old” pathway as “novel” target for anti‐inflammatory drug discovery

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Liuxin Lu, Junjie Li, Xiaoying Jiang, Renren Bai
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Medicinal Research Reviews
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery
by: Shuai‐Jiang Liu, et al.
Published: (2024)

Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer
by: Yiren Yang, et al.
Published: (2024)

Emerging roles of nerve‐bone axis in modulating skeletal system
by: Jingya Li, et al.
Published: (2024)

Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective
by: Dipesh S. Harmalkar, et al.
Published: (2024)

Current emerging therapeutic targets and clinical investigational agents for schizophrenia: Challenges and opportunities
by: Na Ye, et al.
Published: (2024)

OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage
by: Yunxiao Zhong, et al.
Published: (2024)

Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery
by: Roberta Solidoro, et al.
Published: (2024)

Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands
by: Gianfabio Giorgioni, et al.
Published: (2024)

Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders
by: Mirjana Antonijevic, et al.
Published: (2024)

Inside Front Cover Image, Volume 44, Issue 2
by: Yu Zheng, et al.
Published: (2024)

Harnessing the Power of Natural Products for Targeted Protein Degradation
by: Bo Zhu, et al.
Published: (2025)

Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases
by: Chao Yang, et al.
Published: (2024)

Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel
by: Vijay K. Boda, et al.
Published: (2024)

An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators
by: Wanting Hao, et al.
Published: (2024)

Cuproptosis: Mechanism, role, and advances in urological malignancies
by: Jialong Wu, et al.
Published: (2024)

Front Cover Image, Volume 45, Issue 4
by: Nicola Bauer, et al.
Published: (2025)

Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers
by: Yang Yang, et al.
Published: (2025)

HMGB1: From Molecular Functions to Clinical Applications in Cancer and Inflammatory Diseases
by: Linghong Guo, et al.
Published: (2025)

Synthesis and Clinical Application of Small‐Molecule Drugs Approved by FDA in 2025
by: Liang Chang, et al.
Published: (2026)

The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer
by: Yi‐Ru Bai, et al.
Published: (2024)

A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer
by: Xin Xue, et al.
Published: (2026)

Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions
by: Linyue Bai, et al.
Published: (2026)

The Evolution of Benzodiazepine Allosteric Modulators: Structural Insights From Historical Milestones to Emerging Innovations in Drug Discovery and Development
by: Hongyu Jiang, et al.
Published: (2025)

Cutting‐Edge Therapy and Immune Escape Mechanisms in EBV‐Associated Tumors
by: Jie Wang, et al.
Published: (2025)

1,2,4,5‐Tetraoxane derivatives/hybrids as potent antimalarial endoperoxides: Chronological advancements, structure−activity relationship (SAR) studies and future perspectives
by: Abdul Rahaman T. A., et al.
Published: (2024)

Inside Front Cover Image, Volume 44, Issue 5
by: Shuai‐Jiang Liu, et al.
Published: (2024)

An overview of the progress made in research into the Mpox virus
by: Yansheng Li, et al.
Published: (2024)

Recent advances in dietary androgen receptor inhibitors
by: Li Ren, et al.
Published: (2024)

Recent Progress in Azobenzene‐Based In Vivo Photopharmacology
by: Xin Zhou, et al.
Published: (2025)

Insights From Spatiality: Accelerating Pharmaceutical Research Using Mass Spectrometry Imaging
by: Yuchen Zou, et al.
Published: (2026)

Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
by: Xiujin Chang, et al.
Published: (2024)

Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents
by: Xiaoyan Ma, et al.
Published: (2024)

Enhancing healthy aging with small molecules: A mitochondrial perspective
by: Xiujiao Qin, et al.
Published: (2024)

Unlocking Multiscale Allosteric Mechanisms: Advanced Computational Strategies for Drug Discovery
by: Ruidi Zhu, et al.
Published: (2026)

Mucin O‐Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Review
by: Qi‐Di Zhao, et al.
Published: (2026)

FDA‐Approved Pyrimidine‐Containing Drugs: Synthesis and Clinical Application
by: Yao Zhang, et al.
Published: (2025)

Recent Advances of Non‐Nucleoside Polymerase Inhibitors With Broad‐Spectrum Antiviral Activities
by: Sining Tao, et al.
Published: (2026)

Targeting ClpP Protease: Emerging Therapeutic Strategies and Small‐Molecule Modulators in Drug Discovery
by: Lihua Liu, et al.
Published: (2026)

Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
by: Yuchen He, et al.
Published: (2024)

Front Cover Image, Volume 44, Issue 5
by: Qian Zhao, et al.
Published: (2024)